BMG210A71016
BMG210A71016
GRAND PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 12.283.271.000 | 11.644.892.000 | 5.5% |
| Cost of Revenue | 5.502.910.000 | 4.906.576.000 | 12.2% |
| Gross Profit | 6.780.361.000 | 6.738.316.000 | 0.6% |
| 5.096.392.000 | 4.566.282.000 | 11.6% | |
| Operating Income | 1.683.969.000 | 2.172.034.000 | 22.5% |
| Pretax Income | 1.494.081.000 | 2.852.363.000 | 47.6% |
| Net Income Common Stockholders | 1.240.871.000 | 2.468.375.000 | 49.7% |
| -- | -- | -- | |
| -- | -- | -- |